Search Within

Aaron David Goldberg

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (11)
  3. Research Letter (1)
Groups
  1. Adult Leukemia (24)
  2. Center for Hematologic Malignancies (24)
  3. Department of Medicine (24)
  4. Department of Pathology and Laboratory Medicine (24)
  5. Hematologic Malignancies, Division of (24)
  6. Weinberg Fellows (24)

More Groups

People
  1. Christopher Famulare (21)
  2. Martin Tallman (18)
  3. Ross Levine (18)
  4. Mikhail Roshal (17)
  5. Eytan Stein (14)
  6. Jacob Glass (14)

More People

Years
  1. 2025 (1)
  2. 2023 (5)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (5)
  6. 2019 (3)

More Years

Publications
  1. Blood (12)
  2. Blood Advances (3)
  3. American Journal of Hematology (2)
  4. Leukemia and Lymphoma (2)
  5. Cancer Discovery (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. American Society of Clinical Oncology (2)
  3. John Wiley & Sons, Inc. (2)
  4. Taylor & Francis Group (2)
  5. Amer Assoc Advancement Science (1)
  6. American Association for Cancer Research (1)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
    Research Letter

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition
    Journal Article

    Cai, S. F.; Chu, S. H.; Goldberg, A. D.; Parvin, S.; Koche, R. P.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C. A.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
    Journal Article

    Ball, B. J.; Famulare, C. A.; Stein, E. M.; Tallman, M. S.; Derkach, A.; Roshal, M.; Gill, S. I.; Manning, B. M.; Koprivnikar, J.; McCloskey, J.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Leukemia cell of origin influences p53 activity and therapeutic sensitivity via an Evi1-dependent mechanism
    Meeting Abstract

    Cai, S. F.; Chu, S.; Goldberg, A. D.; Parvin, S.; Koche, R.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • P2RY8-CRLF2 fusion–positive acute myeloid leukemia with myelodysplasia-related changes: Response to novel therapy
    Journal Article

    Aypar, U.; Taylor, J.; Garcia, J. S.; Momeni-Boroujeni, A.; Gao, Q.; Baik, J.; Londono, D.; Benayed, R.; Sigler, A.; Haddadin, M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save